Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Director | January 11, 2021 | January 13, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date January 11, 2021 · Filed January 13, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,443 |
Ending reported balance
After 2021-01-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-01-11 · Exercise / conversion · Acquired 5,867 · Balance 11,310 Row 2 · 2021-01-11 · Sale · Disposed 5,867 · Balance 5,443 F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $45.00 to $45.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.78 · Expires 2028-01-24 | Direct | 34,500 |
Reported balance
After 2021-01-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-01-11 · Exercise / conversion · Disposed 5,867 · Balance 34,500 F3: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1.
F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $45.00 to $45.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
F3: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 11, 2021 Filed Jan 13, 2021 23:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,867 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-000343 · primarydocument.xml · derivative · entry 3 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,500 Underlying: Common Stock · 5,867 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 23:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 5,867 | $45.04 | $264,223.87 |
DisclosureSEC source: 0001562180-21-000343 · primarydocument.xml · nonDerivative · entry 2 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $45.00 to $45.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 23:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 5,867 | $11.78 | $69,113.26 |
DisclosureSEC source: 0001562180-21-000343 · primarydocument.xml · nonDerivative · entry 1 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 00:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,501 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-20-007480 · primarydocument.xml · derivative · entry 6 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,367 Underlying: Common Stock · 5,501 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 00:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 5,501 | $45.10 | $248,113.25 |
DisclosureSEC source: 0001562180-20-007480 · primarydocument.xml · nonDerivative · entry 4 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $45.00 to $45.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 00:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 5,501 | $11.78 | $64,801.78 |
DisclosureSEC source: 0001562180-20-007480 · primarydocument.xml · nonDerivative · entry 3 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 24, 2020 Filed Dec 30, 2020 00:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,300 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-20-007480 · primarydocument.xml · derivative · entry 5 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,868 Underlying: Common Stock · 7,300 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| December 24, 2020 Filed Dec 30, 2020 00:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 7,300 | $45.08 | $329,107.36 |
DisclosureSEC source: 0001562180-20-007480 · primarydocument.xml · nonDerivative · entry 2 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $45.00 to $45.31 per share, inclusive. Read SEC document |
| December 24, 2020 Filed Dec 30, 2020 00:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 7,300 | $11.78 | $85,994.00 |
DisclosureSEC source: 0001562180-20-007480 · primarydocument.xml · nonDerivative · entry 1 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,333 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-20-007337 · primarydocument.xml · derivative · entry 4 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,168 Underlying: Common Stock · 2,333 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 100 | $39.17 | $3,917.00 |
DisclosureSEC source: 0001562180-20-007337 · primarydocument.xml · nonDerivative · entry 3 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,233 | $38.73 | $86,481.86 |
DisclosureSEC source: 0001562180-20-007337 · primarydocument.xml · nonDerivative · entry 2 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,543 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $38.17 to $39.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:53 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,333 | $11.78 | $27,482.74 |
DisclosureSEC source: 0001562180-20-007337 · primarydocument.xml · nonDerivative · entry 1 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2020 Filed Nov 17, 2020 22:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,333 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-20-006730 · primarydocument.xml · derivative · entry 4 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,501 Underlying: Common Stock · 2,333 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| November 14, 2020 Filed Nov 17, 2020 22:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,033 | $34.45 | $70,038.88 |
DisclosureSEC source: 0001562180-20-006730 · primarydocument.xml · nonDerivative · entry 3 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.08 to $34.93, inclusive. Read SEC document |
| November 14, 2020 Filed Nov 17, 2020 22:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,333 | $11.78 | $27,482.74 |
DisclosureSEC source: 0001562180-20-006730 · primarydocument.xml · nonDerivative · entry 2 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 22:57 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 300 | $35.52 | $10,655.01 |
DisclosureSEC source: 0001562180-20-006730 · primarydocument.xml · nonDerivative · entry 1 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,143 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.49 to $35.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 23:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,333 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-20-006377 · primarydocument.xml · derivative · entry 3 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,834 Underlying: Common Stock · 2,333 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 23:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,333 | $35.25 | $82,247.35 |
DisclosureSEC source: 0001562180-20-006377 · primarydocument.xml · nonDerivative · entry 2 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $34.80 to $35.59 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 14, 2020 Filed Oct 16, 2020 23:00 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,333 | $11.78 | $27,482.74 |
DisclosureSEC source: 0001562180-20-006377 · primarydocument.xml · nonDerivative · entry 1 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 00:45 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,333 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-20-006022 · primarydocument.xml · derivative · entry 4 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,167 Underlying: Common Stock · 2,333 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 00:45 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 339 | $35.99 | $12,200.51 |
DisclosureSEC source: 0001562180-20-006022 · primarydocument.xml · nonDerivative · entry 3 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F3 · price: Represents the weighted average sale price of the shares sold ranging from $35.94 to $36.09 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and footnote 2. Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 00:45 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,994 | $35.39 | $70,568.66 |
DisclosureSEC source: 0001562180-20-006022 · primarydocument.xml · nonDerivative · entry 2 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,782 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $34.94 to $35.82 per share, inclusive. Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 00:45 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,333 | $11.78 | $27,482.74 |
DisclosureSEC source: 0001562180-20-006022 · primarydocument.xml · nonDerivative · entry 1 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2020 Filed Jun 17, 2020 23:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 5,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004561 · primarydocument.xml · nonDerivative · entry 1 Ferris Timothy G. · CIK 0001782932 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,443 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the date of the next Annual Meeting of the Issuer's Stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.